Official Release Repository: CDC

A reverse chronological list of vaccine licensure announcements from FDA, vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC, and other resources from government sources. Use filters to narrow your search.

Mobile-Friendly

Vaccine Topics

General Topics

Patient Safety Honor Rolls

Official Release Repository

ACIP recommends use of updated COVID-19 vaccines for persons 6 months of age and older

ACIP recommends RSV vaccine (Abrysvo, Pfizer) for pregnant persons at 32–36 weeks' gestation using seasonal administration (September–January in most of the United States) to prevent RSV-associated lower respiratory infections in infants less than 6 months of age

ACIP recommends RSV vaccine (Abrysvo, Pfizer) for pregnant persons at 32–36 weeks' gestation using seasonal administration (September–January in most of the United States) to prevent RSV-associated lower respiratory infections in infants less than 6 months of age

ACIP recommendations on the use of PCV20 (Pfizer) for children

Recommendations for Prevention and Control of Influenza in Children, 2019–2020 - AAP Policy Statement

ACIP recommendations for the use of pneumococcal vaccines in adults 19 years of age and older

ACIP recommendations on use of nirsevimab (Beyfortus, Sanofi) for infants aged less than 8 months born during or entering their first RSV season and for infants and children aged 8–19 months who are at increased risk of severe RSV disease entering their second RSV season.

Prevention and Control of Seasonal Influenza with Vaccines, 2023-24

ACIP recommendations on use of Respiratory Syncytial Virus (RSV) vaccines (Pfizer Abrysvo and GSK Arexvy) in older adults

ACIP interim recommendations for use of bivalent mRNA vaccines for persons aged 6 months – 5 years, adults 65 and older, and for those with immunocompromising conditions

Updated Recommendation from ACIP for Use of Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — U.S. April 2021

ACIP recommends Priorix (GSK) as an additional option to prevent MMR according to existing vaccine recommendations and off-label uses, US, 2022

ACIP interim recommendations for the use of bivalent booster doses of COVID-19 vaccines, US October 2022

ACIP recommendation for the use of cholera (Vaxchora, Emergent Biosolutions) vaccine

ACIP recommends use of PCV15 as an option for pneumococcal vaccination for children under 19 years of age, using currently recommended PCV13 dosing and schedules

Prevention and Control of Seasonal Influenza with Vaccines, 2022-23

ACIP interim recommendation for use of Novavax COVID-19 vaccine in adults 18 years and older, US, July 2022

ACIP interim recommendations for use of Moderna and Pfizer-BioNTech COVID-19 vaccines in children aged 6 Months–5 Years — US, June 2022

ACIP recommendations for use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses, US, 2022

ACIP updates rabies vaccine recommendations - Use of a modified preexposure prophylaxis vaccination schedule to prevent human rabies, US, 2022

Our Affiliated Sites

Support Our Work

Subscribe to IZ Express